Achieving High Performing Health Systems : Putting the social into health care
AUSTRALIAN PRIMARY HEALTHCARE INNOVATION AND REFORM VODCAST SERIES. Highlights from Vodcast 2
A Joint Prestantia Health and AUDIENCED Production, with
– Dr Paresh Dawda, GP Lead and Adviser, Founder Prestantia Health
– Dr Wally Jammal, GP, Hills Family General Practice
– Dr Bogdan Chiva Giurca, Clinical Lead and Global Director, UK National Academy for Social Prescribing
FACILITATOR
Leanne Wells, Associate Consultant, Prestantia Health
Clinicians and consumers know only too well that life circumstances such as poor housing, income and food insecurity can have a negative impact on health outcomes. Conversely, participation in community activities, social connection and access to nature parks and leisure facilities can help maintain health and wellbeing.
More recent phenomena in public health have also focused us on the health and social care connection. Stress factors such as the sudden loss of employment and social interaction, moving to remote work or schooling, and the impacts of sudden, localised COVID-19 ‘lockdowns’ to prevent further outbreaks were triggers of increased psychological distress.
And loneliness is being described as our latest epidemic with chronic loneliness inked to a myriad of health problems and earlier death. A recent report found one in four Australians say they feel persistently lonely, and that loneliness costs $2.7 bn a year in health costs alone.
According to a 2024 Commonwealth Fund Mirror Mirror report, which compares the health performance of several countries, only 13% of Australian primary care providers (or other personnel in the practice) usually screen or assess patients for one or more social need – the third lowest in the OECD.
Primary care – predominantly general practices – is where most people get most of their health care and is a commonly visited health care setting. GPs and others in team have a continuous relationship with their patient and the opportunity to identify factors beyond immediate medical care that can impact on health and wellbeing.
Integrating health and social care is an exciting frontier in healthcare and was described as such by Australia’s Assistant Health Minister at a National Social Prescribing roundtable hosted by the Australian Social Prescribing Research Institute (ASPIRE).
Despite the recognition that primary care is a good place to start, the barriers are real. Practice systems, data systems with the capacity to capture information and make intelligent insights, the lack of flexible funding and the time pressures on practices are among them.
In this Australian Health Journal HIGHLIGHTS release, the panel discuss some of these barriers and the desire to put the social into health care.
The FULL LENGTH FEATURE of this VODCAST can be watched here https://youtu.be/KGjrLcjgFg0
Vodcast 2 was convened December 2024. Read the Prestantia Health Blog Post https://www.prestantiahealth.com/post/putting-the-social-into-health-care
You Might also like
-
Research finds many practitioners feel underprepared to navigate men’s distress
Movember’s Men in Mind expands nationally to equip mental health professionals with the tools to better connect with men before they reach crisis point. Research conducted by the Men’s Health Research team at Movember has found men account for three in every four suicide deaths in Australia, and more than 50% had sought help in the year before they died.
-
Developing the next generation of medicines to target and enhance the microbiome
Australian Health Journal spoke to Associate Professor Sam Forster, Research Group Head
Microbiota and Systems Biology, Hudson Institute of Medical Research, Team Leader, Australian Microbiome Culture Collection & Chief Scientific Officer, BiomeBank and Dr Sam Costello, Co-Founder and CEO of BiomeBank about the microbiome, partnering and some of the breakthroughs in recent years. -
New option for management of high-risk soft tissue sarcoma of the limb
SARC032 is the first completed randomised clinical trial of its kind and has demonstrated compelling evidence to integrate immunotherapy, with the standard treatment regimen of radiotherapy and surgery for patients with grade 2 or 3, stage III soft tissue sarcoma of the limb.